National Health Act 1953 - Arrangements made under subparagraph 100(1)(b)(i) - Highly Specialised Drugs Program (No. PB 36 of 2006)
Cost to patient of highly specialised drCost to patient of highly specialised drugs under these Arrangements
Start here
Get a plain-English read of Cost to patient of highly specialised dr
Turn the raw legal text into a practical explanation grounded in National Health Act 1953 - Arrangements made under subparagraph 100(1)(b)(i) - Highly Specialised Drugs Program (No. PB 36 of 2006).
Cost to patient of highly specialised drugs under these Arrangements
- An approved pharmacist or an approved hospital authority who supplies a highly specialised drug may charge the person to whom the highly specialised drug is supplied an amount equivalent to the amount that may be charged under section 87 of the Act for the supply of a pharmaceutical benefit to the person.
19A. In addition to the amount that may be charged by an approved pharmacist or an approved hospital authority under paragraph 19, an approved pharmacist or an approved hospital authority who supplies a highly specialised drug which is:
(i) named in column 1 of Schedule 4;
(ii) in the form specified in column 2 of Schedule 4 in relation to that highly specialised drug;
(iii) marketed under the brand specified in column 3 of Schedule 4 in relation to that highly specialised drug; and
(iv) in the quantity or number of units specified in column 4 of Schedule 4 in relation to that highly specialised drug;
may charge the person to whom the highly specialised drug is supplied the amount calculated by subtracting the amount specified in column 5 of Schedule 4 in relation to that highly specialised drug from the amount specified in column 6 of Schedule 4 in relation to that highly specialised drug.